BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24952616)

  • 21. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
    Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
    Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.
    Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M
    J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis.
    Caporale AS; Chiarelli AM; Biondetti E; Villani A; Lipp I; Di Censo D; Tomassini V; Wise RG
    Hum Brain Mapp; 2024 Jun; 45(9):e26761. PubMed ID: 38895882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
    Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
    J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study.
    Fuchs TA; Carolus K; Benedict RHB; Bergsland N; Ramasamy D; Jakimovski D; Weinstock-Guttman B; Kuceyeski A; Zivadinov R; Dwyer MG
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1480-1486. PubMed ID: 29976833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.
    Bussas M; Grahl S; Pongratz V; Berthele A; Gasperi C; Andlauer T; Gaser C; Kirschke JS; Wiestler B; Zimmer C; Hemmer B; Mühlau M
    Mult Scler; 2022 May; 28(6):900-909. PubMed ID: 34591698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis.
    Fiore A; Preziosa P; Tedone N; Margoni M; Vizzino C; Mistri D; Gueye M; Rocca MA; Filippi M
    Mol Psychiatry; 2023 Apr; 28(4):1770-1782. PubMed ID: 36658334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5 year MRI study.
    De Meo E; Meani A; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
    Neurology; 2019 Apr; 92(15):e1709-e1723. PubMed ID: 30867274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    Rektor I; Svátková A; Vojtíšek L; Zikmundová I; Vaníček J; Király A; Szabó N
    PLoS One; 2018; 13(1):e0187939. PubMed ID: 29304183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
    Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
    J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
    Zhang J; Giorgio A; Vinciguerra C; Stromillo ML; Battaglini M; Mortilla M; Tappa Brocci R; Portaccio E; Amato MP; De Stefano N
    Mult Scler; 2021 Jan; 27(1):39-51. PubMed ID: 31976807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
    MacKenzie-Graham A; Brook J; Kurth F; Itoh Y; Meyer C; Montag MJ; Wang HJ; Elashoff R; Voskuhl RR
    Brain Behav; 2018 Sep; 8(9):e01086. PubMed ID: 30144306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
    Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R
    Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.